Evidence map›Paper›PMID 27880903›Full record

ArticleCell reports2016

miRNAs Are Essential for the Regulation of the PI3K/AKT/FOXO Pathway and Receptor Editing during B Cell Maturation.

Maryaline Coffre, David Benhamou, David Rieß, Lili Blumenberg, Valentina Snetkova, Marcus J Hines, Tirtha Chakraborty, Sofia Bajwa, Kari Jensen, Mark M W Chong and 9 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. An Emerging Role ofOxidative medicine and cellular longevity · 2022
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. FoxO transcription factors 1 regulate mouse preimplantation embryo development.Journal of assisted reproduction and genetics · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

Maryaline CoffreDepartment of Pathology, New York University School of Medicine, New York, NY 10016, USA.
David BenhamouDepartment of Immunology, Faculty of Medicine, Technion, Haifa 31096, Israel.
David RießHarvard Medical School, Pathology, Boston, MA 02115, USA.
Lili BlumenbergDepartment of Pathology, New York University School of Medicine, New York, NY 10016, USA.
Valentina SnetkovaDepartment of Pathology, New York University School of Medicine, New York, NY 10016, USA.
Marcus J HinesDepartment of Pathology, New York University School of Medicine, New York, NY 10016, USA.
Tirtha ChakrabortyHarvard Medical School, Pathology, Boston, MA 02115, USA.
Sofia BajwaDepartment of Pathology, New York University School of Medicine, New York, NY 10016, USA.
Kari JensenHarvard Medical School, Pathology, Boston, MA 02115, USA.
Mark M W ChongSkirball Institute, NYU School of Medicine, New York, NY 10016, USA.
Lelise GetuDepartment of Medicine, NYU School of Medicine, New York, NY 10016, USA.
Gregg J SilvermanDepartment of Pathology, New York University School of Medicine, New York, NY 10016, USA; Department of Medicine, NYU School of Medicine, New York, NY 10016, USA.
Robert BlellochDepartment of Urology, UCSF, San Francisco, CA 94143, USA.
Dan R LittmanSkirball Institute, NYU School of Medicine, New York, NY 10016, USA; The HHMI, NYU School of Medicine, New York, NY 10016, USA.
Dinis CaladoHarvard Medical School, Pathology, Boston, MA 02115, USA.
Doron MelamedDepartment of Immunology, Faculty of Medicine, Technion, Haifa 31096, Israel.
Jane A SkokDepartment of Pathology, New York University School of Medicine, New York, NY 10016, USA.
Klaus RajewskyHarvard Medical School, Pathology, Boston, MA 02115, USA.
Sergei B KoralovDepartment of Pathology, New York University School of Medicine, New York, NY 10016, USA. Electronic address: sergei.koralov@nyumc.org.
New York University · USHarvard University · USTechnion – Israel Institute of Technology · ILUniversity of California, San Francisco · US

Funding

MEDICAL SCIENTIST TRAININGT32GM007308 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PHILIPS, MARK REID · 1985 to 2019
$23.2M
Role of RNA silencing in B cell development and functionR01AI064345 · NIAID · IMMUNE DISEASE INSTITUTE, INC. · PI RAJEWSKY, KLAUS · 2005 to 2009
$2.9M
Non-coding RNAs in B lymphocyte development and functionR21AI110830 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KORALOV, SERGEI BORISOVICH · 2014 to 2014
$170k
Cancer Research UK 16857Medical Research Council MR/J008060/1NIAID NIH HHS R01 AI064345NIAID NIH HHS R21 AI110830NIGMS NIH HHS T32 GM007308
6 · The paper itself

Abstract

B cell development is a tightly regulated process dependent on sequential rearrangements of immunoglobulin loci that encode the antigen receptor. To elucidate the role of microRNAs (miRNAs) in the orchestration of B cell development, we ablated all miRNAs at the earliest stage of B cell development by conditionally targeting the enzymes critical for RNAi in early B cell precursors. Absence of any one of these enzymes led to a block at the pro- to pre-B cell transition due to increased apoptosis and a failure of pre-B cells to proliferate. Expression of a Bcl2 transgene allowed for partial rescue of B cell development, however, the majority of the rescued B cells had low surface immunoglobulin expression with evidence of ongoing light chain editing. Our analysis revealed that miRNAs are critical for the regulation of the PTEN-AKT-FOXO1 pathway that in turn controls Rag expression during B cell development.

Indexed as

Gene Expression RegulationAnimalsB-LymphocytesCell DifferentiationDown-RegulationForkhead Transcription FactorsImmunoglobulin Light ChainsMiceMicroRNAsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-bcl-2Receptors, Antigen, B-CellRibonuclease IIIRNA-Binding ProteinsRNA EditingDgcr8 protein, mouseDrosha protein, mouseForkhead Transcription FactorsImmunoglobulin Light ChainsMicroRNAsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-bcl-2Receptors, Antigen, B-CellRibonuclease IIIRNA-Binding ProteinsB cell developmentB lymphocytesDGCR8DicerDroshamiRNAPI3K/AKTPTENRAGreceptor editing

Identifiers

PMID27880903
PMCPMC5679080
OpenAlexW2556845933

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.